Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism
- 1 May 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (5), 711-717
- https://doi.org/10.1128/aac.21.5.711
Abstract
Resistance to cefotaxime (CTA) and ceftriaxone (CTR) in Enterobacter cloacae and Pseudomonas aeruginosa was investigated in several strains which are susceptible or resistant to these agents. All strains produced a chromosomally mediated cephalosporinase of the Richmond type 1. beta-Lactamases in susceptible strains were inducible, whereas resistant strains produced the enzymes constitutively. CTA and CTR were very poor substrates but potent inhibitors of all enzymes. Binding to, rather than hydrolysis by, beta-lactamases was assumed to be a major reason for resistance, and combination experiments supported this assumption. Dicloxacillin, which did not inhibit the growth and which was a poor inducer but a strong inhibitor of these beta-lactamases, exerted strong synergistic activity when combined with CTA or CTR in strains which produced large amounts of beta-lactamase constitutively. Cefoxitin, on the other hand, poorly active alone, but a good inducer, strongly antagonized CTA or CTR in susceptible strains producing inducible enzymes. In marked contrast to CTA and CTR were the findings with cefsulodin. Cefsulodin was active against CTA- and CTR-resistant Pseudomonas, and its activity was hardly influenced by dicloxacillin or cefoxitin. Since cefsulodin was found to have a very low affinity for all cephalosporinases, these findings corroborate the assumption that binding of nonhydrolyzable cephalosporins, rather than hydrolysis by cephalosporinases, may play an important role in resistance to these agents and other newer cephalosporins in Enterobacteriaceae, as well as in other gram-negative bacteria.This publication has 30 references indexed in Scilit:
- In vitro and in vivo antibacterial effects of combinations of beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1981
- Properties of Ro 13-9904 as a Substrate and Inhibitor of %beta;-LactamasesChemotherapy, 1981
- The role of inducible β-lactamases in the antagonism seen with certain cephalosporin combinationsJournal of Antimicrobial Chemotherapy, 1981
- Purification and Properties of Chromosomally Mediated -Lactamase from Citrobacter freundii GN7391Microbiology, 1980
- The β-lactamase stability of a novel β-lactam antibiotic containing a 7 α-methoxyoxacephem nucleusJournal of Antimicrobial Chemotherapy, 1980
- .beta.-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitinBiochemistry, 1980
- Inactivation of cephalosponins In blood cultures and mixed assays with a commercially available enterobacter β-lactainaseJournal of Antimicrobial Chemotherapy, 1979
- CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological CharacterizationAntimicrobial Agents and Chemotherapy, 1978
- Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and CefoxitinAntimicrobial Agents and Chemotherapy, 1978
- THE DEMONSTRATION AND SIGNIFICANCE OF SYNERGISM BETWEEN -LACTAM ANTIBIOTICSJournal of Medical Microbiology, 1971